Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Antczak

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2015
A High-Content Assay to Screen for Modulators of EGFR FunctionChristophe Antczak, Hakim Djaballah
Journal of Biomolecular Screening|March 20, 2008
A profiling platform for the identification of selective metalloprotease inhibitorsChristophe Antczak, Constantin Radu, Hakim Djaballah
Expert Opinion on Drug Discovery|July 25, 2012
Cell viability assessment: toward content-rich platformsChristina Nicole Ramirez, Christophe Antczak, Hakim Djaballah
Journal of Biomolecular Screening|September 4, 2009
Live-cell imaging of caspase activation for high-content screeningChristophe Antczak, Toshimitsu Takagi, Christina N Ramirez, et al.
Combinatorial Chemistry & High Throughput Screening|March 12, 2009
Development and validation of a high-density fluorescence polarization-based assay for the trypanosoma RNA triphosphatase TbCet1Christophe Antczak, David Shum, Constantin Radu, et al.
Combinatorial Chemistry & High Throughput Screening|August 21, 2013
A high content assay to assess cellular fitnessChristophe Antczak, Jeni P Mahida, Chanpreet Singh, et al.
Journal of Biomolecular Screening|May 11, 2012
A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discoveryChristophe Antczak, Jeni P Mahida, Bhavneet Bhinder, et al.
Future Medicinal Chemistry|April 16, 2015
Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell modelsShane R Horman, Christopher Hogan, Karlo Delos Reyes, et al.
Assay and Drug Development Technologies|August 12, 2017
How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of PracticeDorothea Haasen, Ulrich Schopfer, Christophe Antczak, et al.
Assay and Drug Development Technologies|September 3, 2013
A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cellsChristophe Antczak, Boyoung Wee, Constantin Radu, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|October 27, 2015
A High-Content Assay to Screen for Modulators of EGFR FunctionChristophe Antczak, Hakim Djaballah
Journal of Biomolecular Screening|March 20, 2008
A profiling platform for the identification of selective metalloprotease inhibitorsChristophe Antczak, Constantin Radu, Hakim Djaballah
Expert Opinion on Drug Discovery|July 25, 2012
Cell viability assessment: toward content-rich platformsChristina Nicole Ramirez, Christophe Antczak, Hakim Djaballah
Journal of Biomolecular Screening|September 4, 2009
Live-cell imaging of caspase activation for high-content screeningChristophe Antczak, Toshimitsu Takagi, Christina N Ramirez, et al.
Combinatorial Chemistry & High Throughput Screening|March 12, 2009
Development and validation of a high-density fluorescence polarization-based assay for the trypanosoma RNA triphosphatase TbCet1Christophe Antczak, David Shum, Constantin Radu, et al.
Combinatorial Chemistry & High Throughput Screening|August 21, 2013
A high content assay to assess cellular fitnessChristophe Antczak, Jeni P Mahida, Chanpreet Singh, et al.
Journal of Biomolecular Screening|May 11, 2012
A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: implications in drug discoveryChristophe Antczak, Jeni P Mahida, Bhavneet Bhinder, et al.
Future Medicinal Chemistry|April 16, 2015
Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell modelsShane R Horman, Christopher Hogan, Karlo Delos Reyes, et al.
Assay and Drug Development Technologies|August 12, 2017
How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of PracticeDorothea Haasen, Ulrich Schopfer, Christophe Antczak, et al.
Assay and Drug Development Technologies|September 3, 2013
A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cellsChristophe Antczak, Boyoung Wee, Constantin Radu, et al.
Pageof 5